CMR SurgicalNot yet claimed

About CMR Surgical

CMR Surgical is a Cambridge, United Kingdom company that builds surgical robots to make minimally invasive (keyhole) surgery more widely available. Founded in 2014, its Versius system — now in its second generation as Versius Plus — is a modular, portable robotic platform whose arms mimic the human arm and wrist, designed so hospitals can fit robotic surgery into existing operating rooms and workflows rather than building dedicated suites. The company states that Versius is the world’s second most-used surgical robotic platform (company-stated), with more than 45,000 procedures completed by the end of September 2026 and regulatory clearances across Europe, Latin America, Asia-Pacific and Australia.

In 2025 the system received US FDA 510(k) clearance for gallbladder removal, and in October 2026 the company announced a strategic partnership under which a major US medical-technology group becomes its exclusive US commercial agent, alongside a large investment with an option to acquire the company outright. For partners, CMR matters as the leading non-US challenger in surgical robotics: a clinically established platform, manufactured at its own hub in Ely, England, that is now entering the world’s largest surgical market through an established distribution partner.

Products & services

• Versius Plus — current-generation surgical robotic system (FDA 510(k) cleared for cholecystectomy), with modular arms and an open console
• Versius — original surgical robotic system in clinical use worldwide
• vLimeLite — fluorescence imaging visualisation tool for use with Versius Plus
• Versius Connect and Versius Team — companion apps supporting surgical teams and case data
• Robotic instrument portfolio and structured training programmes for adopting hospitals

Questions partners ask

GlobleMatch Trust Signals

A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.

Public information coverage	8 of 9 fields on the standard profile could be filled from public sources. This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself.
Last verified	6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed.

Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.

Sources & verification

• Company website — cmrsurgical.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
• Funding and listing details — Tracxn and the parties' joint announcement, via GlobleMatch funding research files. Checked 6 November 2026.
• Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.

Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.

Related companies

More in Robotics & hardware: DFRobot (open-source hardware, maker and stem products, China) · Exotec (as/rs systems & integration, France) · Figure AI (humanoid / general-purpose, United States)

Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.